MPR NewsMPR News

Sydney Lupkin

Recent Contributions

  • As Ozempic use grows, so do reports of possible mental health side effects
  • Here are the first 10 drugs that Medicare will target for price cuts
  • Pfizer's RSV vaccine to protect babies gets greenlight from FDA
  • Blockbuster drug Humira finally faces lower-cost rivals
  • Strep is bad right now — an antibiotic shortage is making it worse
  • Moderna's COVID vaccine gambit: Hike the price, offer free doses for uninsured
  • FDA has new leverage over companies looking for a quicker drug approval
  • Adderall shortage forces some patients to scramble, ration or go without
  • Is it time for a reality check on rapid COVID tests?
  • Feds' contract with Pfizer for Paxlovid has some surprises